Your browser doesn't support javascript.
loading
Feasibility and utility of in-home body weight support harness system use in young children treated for spinal muscular atrophy: A single-arm prospective cohort study.
Iammarino, Megan A; Alfano, Lindsay N; Reash, Natalie F; Sabo, Brenna; Conroy, Sara; Noritz, Garey; Wendland, Madalynn; Lowes, Linda P.
Afiliação
  • Iammarino MA; Center for Gene Therapy, Nationwide Children's Hospital, Columbus, Ohio, United States of America.
  • Alfano LN; Center for Gene Therapy, Nationwide Children's Hospital, Columbus, Ohio, United States of America.
  • Reash NF; Department of Pediatrics, The Ohio State University, Columbus, Ohio, United States of America.
  • Sabo B; Center for Gene Therapy, Nationwide Children's Hospital, Columbus, Ohio, United States of America.
  • Conroy S; Center for Gene Therapy, Nationwide Children's Hospital, Columbus, Ohio, United States of America.
  • Noritz G; Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
  • Wendland M; Biostatistics Resource at Nationwide Children's Hospital, Nationwide Children's Hospital, Columbus, Ohio, United States of America.
  • Lowes LP; Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio, United States of America.
PLoS One ; 19(3): e0300244, 2024.
Article em En | MEDLINE | ID: mdl-38502672
ABSTRACT

PURPOSE:

This single-arm prospective cohort study aimed to evaluate the feasibility and utility of in-home body weight support harness system (BWSS) use in children treated for spinal muscular atrophy (SMA).

METHODS:

Individuals with 2 or 3 copies of SMN2 who received pharmacotherapeutic treatment, had head control, and weight <50lbs were enrolled. Families were provided a BWSS and documented use. Motor outcome assessments were completed at baseline, month 3 and month 6. Families provided feedback in an end of study survey.

RESULTS:

All 32 participants (2.9 (SD 1.9) yrs), improved or remained stable on all outcomes. Average reported frequency of use was 4.1(2.3) hrs/week. Controlling for other covariates, frequency of use explained over 70% of the variability in change scores. Family feedback was overwhelmingly positive.

CONCLUSION:

Use of in-home BWSS is a safe, feasible and useful option to increase exercise dosage after treatment in SMA and may help optimize motor abilities. TRIAL REGISTRATION Study registered with Clinicaltrials.gov Clinicaltrials.gov identifier NCT05715749.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia Muscular Espinal / Atrofias Musculares Espinais da Infância Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia Muscular Espinal / Atrofias Musculares Espinais da Infância Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article